{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20220826",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "71937",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213736s002lbl.pdf",
              "date": "20220826",
              "type": "Label"
            },
            {
              "id": "71940",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/213736Orig1s002ltr.pdf",
              "date": "20220829",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210223",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "66341",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213736s001lbl.pdf",
              "date": "20210224",
              "type": "Label"
            },
            {
              "id": "66346",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/213736Orig1s001ltr.pdf",
              "date": "20210224",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200417",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "62593",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf",
              "date": "20200420",
              "type": "Label"
            },
            {
              "id": "62595",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/213736Orig1s000ltr.pdf",
              "date": "20200420",
              "type": "Letter"
            },
            {
              "id": "63054",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213736Orig1s000TOC.html",
              "date": "20200518",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA213736",
      "sponsor_name": "INCYTE CORP",
      "openfda": {
        "application_number": [
          "NDA213736"
        ],
        "brand_name": [
          "PEMAZYRE"
        ],
        "generic_name": [
          "PEMIGATINIB"
        ],
        "manufacturer_name": [
          "Incyte Corporation"
        ],
        "product_ndc": [
          "50881-026",
          "50881-027",
          "50881-028"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "PEMIGATINIB"
        ],
        "spl_id": [
          "741de3ad-f255-4da5-b43a-60a99caf4137"
        ],
        "spl_set_id": [
          "9e1f2222-1d89-4e63-989c-ccebe2ab1eb4"
        ],
        "package_ndc": [
          "50881-026-01",
          "50881-027-01",
          "50881-028-01"
        ],
        "nui": [
          "N0000175605",
          "N0000175082",
          "N0000185503",
          "N0000187061",
          "N0000191423"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Kinase Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Organic Cation Transporter 2 Inhibitors [MoA]",
          "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]"
        ],
        "unii": [
          "Y6BX7BL23K"
        ]
      },
      "products": [
        {
          "product_number": "003",
          "reference_drug": "Yes",
          "brand_name": "PEMAZYRE",
          "active_ingredients": [
            {
              "name": "PEMIGATINIB",
              "strength": "13.5MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "PEMAZYRE",
          "active_ingredients": [
            {
              "name": "PEMIGATINIB",
              "strength": "4.5MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "PEMAZYRE",
          "active_ingredients": [
            {
              "name": "PEMIGATINIB",
              "strength": "9MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}